Lunch & Learn with AAE: New Medications in Pulmonary Disease

  • 29 Apr 2026
  • 1:00 PM - 2:00 PM
  • https://us02web.zoom.us/j/84599105106?pwd=2BOBHMjhEBKJbtYvwHpCHvBrAXPwHr.1

Registration


Registration is closed


Wednesday, April 29, 2026 

1:00pm EST, 12:00pm CT,  11:00am MT,  10:00am PT


Lunch & Learn with AAE: New Medications in Pulmonary Disease


Topical content will include:

Role of NHLBI in asthma research Asthma Research | NHLBI, NIH

Current treatments under study

Personalized treatments Home | PrecISE


Learning objectives:

  • Review new medications approved for pulmonary disease in the last few years
  • Review new indications for older pulmonary medications
  • Discuss possible future directions


PRESENTERS:

Sujeet Jagpal, MD attended Rutgers Medical School and went on to complete her residency in Internal Medicine at Thomas Jefferson University Hospital and her Fellowship in Pulmonary and Critical Care Medicine at Robert Wood Johnson University Hospital.
Upon completion of her fellowship program in 2014, Dr. Jagpal joined the Rutgers Robert Wood Johnson Medical School as an Associate Director of the Adult Cystic Fibrosis Program as well as the Associate Fellowship Program Director.


Brian H. Zeng, PharmD is a Doctor of Medicine candidate at Rutgers Robert Wood Johnson Medical School, Class of 2029. He previously earned his Doctor of Pharmacy (PharmD) from Rutgers University’s Ernest Mario School of Pharmacy, graduating summa cum laude in 2023. At graduation, he was honored with the Ernest Little Alumni Award, presented to one outstanding member of the graduating class in recognition of exceptional leadership, academic excellence, and commitment to co-curricular involvement.

With a background spanning both pharmacy and medicine, Dr. Zeng brings a unique perspective to patient care that integrates pharmacologic expertise with comprehensive clinical training.